 | • レポートコード：MRC2-11QY01724 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は不眠症治療薬のグローバル市場について調査・分析したレポートです。種類別（非ベンゾジアゼピン受容体作動薬、ベンゾジアゼピン受容体作動薬、選択的メラトニン受容体作動薬ラメルテオン、鎮静抗うつ薬）市場規模、用途別（大人、子供）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別不眠症治療薬の競争状況、市場シェア ・世界の不眠症治療薬市場：種類別市場規模 2015年-2020年（非ベンゾジアゼピン受容体作動薬、ベンゾジアゼピン受容体作動薬、選択的メラトニン受容体作動薬ラメルテオン、鎮静抗うつ薬） ・世界の不眠症治療薬市場：種類別市場規模予測 2021年-2026年（非ベンゾジアゼピン受容体作動薬、ベンゾジアゼピン受容体作動薬、選択的メラトニン受容体作動薬ラメルテオン、鎮静抗うつ薬） ・世界の不眠症治療薬市場：用途別市場規模 2015年-2020年（大人、子供） ・世界の不眠症治療薬市場：用途別市場規模予測 2021年-2026年（大人、子供） ・北米の不眠症治療薬市場分析：米国、カナダ ・ヨーロッパの不眠症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの不眠症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の不眠症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの不眠症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eisai、Merck、Pfizer、Sanofi、Takeda、Vanda Pharmaceuticals、Astellas、Dainippon Sumitomo、ECR Pharmaceuticals (Valeant)、Flynn Pharma、Johnson & Johnson、Meda、Somnus Therapeutics、Purdue Pharma、Neurim、Minerva Neurosciences、Pernix Therapeutics、SkyePharma、Paratek Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Insomnia Medication Market
The global Insomnia Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Insomnia Medication Scope and Market Size
Insomnia Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insomnia Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Insomnia Medication market is segmented into
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Segment by Application, the Insomnia Medication market is segmented into
Adults
Kids
Regional and Country-level Analysis
The Insomnia Medication market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insomnia Medication market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Insomnia Medication Market Share Analysis
Insomnia Medication market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insomnia Medication business, the date to enter into the Insomnia Medication market, Insomnia Medication product introduction, recent developments, etc.
The major vendors covered:
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
1 Study Coverage
1.1 Insomnia Medication Product Introduction
1.2 Market Segments
1.3 Key Insomnia Medication Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Insomnia Medication Market Size Growth Rate by Type
1.4.2 Nonbenzodiazepine Receptor Agonists
1.4.3 Benzodiazepine Receptor Agonists
1.4.4 The Selective Melatonin Receptor Agonist Ramelteon
1.4.5 Sedating Antidepressants
1.5 Market by Application
1.5.1 Global Insomnia Medication Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Kids
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Insomnia Medication Market Size, Estimates and Forecasts
2.1.1 Global Insomnia Medication Revenue 2015-2026
2.1.2 Global Insomnia Medication Sales 2015-2026
2.2 Global Insomnia Medication, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Insomnia Medication Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Insomnia Medication Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Insomnia Medication Competitor Landscape by Players
3.1 Insomnia Medication Sales by Manufacturers
3.1.1 Insomnia Medication Sales by Manufacturers (2015-2020)
3.1.2 Insomnia Medication Sales Market Share by Manufacturers (2015-2020)
3.2 Insomnia Medication Revenue by Manufacturers
3.2.1 Insomnia Medication Revenue by Manufacturers (2015-2020)
3.2.2 Insomnia Medication Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insomnia Medication Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Insomnia Medication Revenue in 2019
3.2.5 Global Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Insomnia Medication Price by Manufacturers
3.4 Insomnia Medication Manufacturing Base Distribution, Product Types
3.4.1 Insomnia Medication Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insomnia Medication Product Type
3.4.3 Date of International Manufacturers Enter into Insomnia Medication Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Insomnia Medication Market Size by Type (2015-2020)
4.1.1 Global Insomnia Medication Sales by Type (2015-2020)
4.1.2 Global Insomnia Medication Revenue by Type (2015-2020)
4.1.3 Insomnia Medication Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Insomnia Medication Market Size Forecast by Type (2021-2026)
4.2.1 Global Insomnia Medication Sales Forecast by Type (2021-2026)
4.2.2 Global Insomnia Medication Revenue Forecast by Type (2021-2026)
4.2.3 Insomnia Medication Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Insomnia Medication Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Insomnia Medication Market Size by Application (2015-2020)
5.1.1 Global Insomnia Medication Sales by Application (2015-2020)
5.1.2 Global Insomnia Medication Revenue by Application (2015-2020)
5.1.3 Insomnia Medication Price by Application (2015-2020)
5.2 Insomnia Medication Market Size Forecast by Application (2021-2026)
5.2.1 Global Insomnia Medication Sales Forecast by Application (2021-2026)
5.2.2 Global Insomnia Medication Revenue Forecast by Application (2021-2026)
5.2.3 Global Insomnia Medication Price Forecast by Application (2021-2026)
6 North America
6.1 North America Insomnia Medication by Country
6.1.1 North America Insomnia Medication Sales by Country
6.1.2 North America Insomnia Medication Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Insomnia Medication Market Facts & Figures by Type
6.3 North America Insomnia Medication Market Facts & Figures by Application
7 Europe
7.1 Europe Insomnia Medication by Country
7.1.1 Europe Insomnia Medication Sales by Country
7.1.2 Europe Insomnia Medication Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insomnia Medication Market Facts & Figures by Type
7.3 Europe Insomnia Medication Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Insomnia Medication by Region
8.1.1 Asia Pacific Insomnia Medication Sales by Region
8.1.2 Asia Pacific Insomnia Medication Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Insomnia Medication Market Facts & Figures by Type
8.3 Asia Pacific Insomnia Medication Market Facts & Figures by Application
9 Latin America
9.1 Latin America Insomnia Medication by Country
9.1.1 Latin America Insomnia Medication Sales by Country
9.1.2 Latin America Insomnia Medication Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Insomnia Medication Market Facts & Figures by Type
9.3 Central & South America Insomnia Medication Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Insomnia Medication by Country
10.1.1 Middle East and Africa Insomnia Medication Sales by Country
10.1.2 Middle East and Africa Insomnia Medication Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Insomnia Medication Market Facts & Figures by Type
10.3 Middle East and Africa Insomnia Medication Market Facts & Figures by Application
11 Company Profiles
11.1 Eisai
11.1.1 Eisai Corporation Information
11.1.2 Eisai Description and Business Overview
11.1.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Insomnia Medication Products Offered
11.1.5 Eisai Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Insomnia Medication Products Offered
11.2.5 Merck Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Insomnia Medication Products Offered
11.3.5 Pfizer Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Insomnia Medication Products Offered
11.4.5 Sanofi Related Developments
11.5 Takeda
11.5.1 Takeda Corporation Information
11.5.2 Takeda Description and Business Overview
11.5.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Takeda Insomnia Medication Products Offered
11.5.5 Takeda Related Developments
11.6 Vanda Pharmaceuticals
11.6.1 Vanda Pharmaceuticals Corporation Information
11.6.2 Vanda Pharmaceuticals Description and Business Overview
11.6.3 Vanda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Vanda Pharmaceuticals Insomnia Medication Products Offered
11.6.5 Vanda Pharmaceuticals Related Developments
11.7 Astellas
11.7.1 Astellas Corporation Information
11.7.2 Astellas Description and Business Overview
11.7.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Astellas Insomnia Medication Products Offered
11.7.5 Astellas Related Developments
11.8 Dainippon Sumitomo
11.8.1 Dainippon Sumitomo Corporation Information
11.8.2 Dainippon Sumitomo Description and Business Overview
11.8.3 Dainippon Sumitomo Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Dainippon Sumitomo Insomnia Medication Products Offered
11.8.5 Dainippon Sumitomo Related Developments
11.9 ECR Pharmaceuticals (Valeant)
11.9.1 ECR Pharmaceuticals (Valeant) Corporation Information
11.9.2 ECR Pharmaceuticals (Valeant) Description and Business Overview
11.9.3 ECR Pharmaceuticals (Valeant) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Products Offered
11.9.5 ECR Pharmaceuticals (Valeant) Related Developments
11.10 Flynn Pharma
11.10.1 Flynn Pharma Corporation Information
11.10.2 Flynn Pharma Description and Business Overview
11.10.3 Flynn Pharma Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Flynn Pharma Insomnia Medication Products Offered
11.10.5 Flynn Pharma Related Developments
11.1 Eisai
11.1.1 Eisai Corporation Information
11.1.2 Eisai Description and Business Overview
11.1.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Insomnia Medication Products Offered
11.1.5 Eisai Related Developments
11.12 Meda
11.12.1 Meda Corporation Information
11.12.2 Meda Description and Business Overview
11.12.3 Meda Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Meda Products Offered
11.12.5 Meda Related Developments
11.13 Somnus Therapeutics
11.13.1 Somnus Therapeutics Corporation Information
11.13.2 Somnus Therapeutics Description and Business Overview
11.13.3 Somnus Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Somnus Therapeutics Products Offered
11.13.5 Somnus Therapeutics Related Developments
11.14 Purdue Pharma
11.14.1 Purdue Pharma Corporation Information
11.14.2 Purdue Pharma Description and Business Overview
11.14.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Purdue Pharma Products Offered
11.14.5 Purdue Pharma Related Developments
11.15 Neurim
11.15.1 Neurim Corporation Information
11.15.2 Neurim Description and Business Overview
11.15.3 Neurim Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Neurim Products Offered
11.15.5 Neurim Related Developments
11.16 Minerva Neurosciences
11.16.1 Minerva Neurosciences Corporation Information
11.16.2 Minerva Neurosciences Description and Business Overview
11.16.3 Minerva Neurosciences Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Minerva Neurosciences Products Offered
11.16.5 Minerva Neurosciences Related Developments
11.17 Pernix Therapeutics
11.17.1 Pernix Therapeutics Corporation Information
11.17.2 Pernix Therapeutics Description and Business Overview
11.17.3 Pernix Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Pernix Therapeutics Products Offered
11.17.5 Pernix Therapeutics Related Developments
11.18 SkyePharma
11.18.1 SkyePharma Corporation Information
11.18.2 SkyePharma Description and Business Overview
11.18.3 SkyePharma Sales, Revenue and Gross Margin (2015-2020)
11.18.4 SkyePharma Products Offered
11.18.5 SkyePharma Related Developments
11.19 Paratek Pharmaceuticals
11.19.1 Paratek Pharmaceuticals Corporation Information
11.19.2 Paratek Pharmaceuticals Description and Business Overview
11.19.3 Paratek Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Paratek Pharmaceuticals Products Offered
11.19.5 Paratek Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Insomnia Medication Market Estimates and Projections by Region
12.1.1 Global Insomnia Medication Sales Forecast by Regions 2021-2026
12.1.2 Global Insomnia Medication Revenue Forecast by Regions 2021-2026
12.2 North America Insomnia Medication Market Size Forecast (2021-2026)
12.2.1 North America: Insomnia Medication Sales Forecast (2021-2026)
12.2.2 North America: Insomnia Medication Revenue Forecast (2021-2026)
12.2.3 North America: Insomnia Medication Market Size Forecast by Country (2021-2026)
12.3 Europe Insomnia Medication Market Size Forecast (2021-2026)
12.3.1 Europe: Insomnia Medication Sales Forecast (2021-2026)
12.3.2 Europe: Insomnia Medication Revenue Forecast (2021-2026)
12.3.3 Europe: Insomnia Medication Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Insomnia Medication Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Insomnia Medication Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Insomnia Medication Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Insomnia Medication Market Size Forecast by Region (2021-2026)
12.5 Latin America Insomnia Medication Market Size Forecast (2021-2026)
12.5.1 Latin America: Insomnia Medication Sales Forecast (2021-2026)
12.5.2 Latin America: Insomnia Medication Revenue Forecast (2021-2026)
12.5.3 Latin America: Insomnia Medication Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Insomnia Medication Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Insomnia Medication Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Insomnia Medication Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Insomnia Medication Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Insomnia Medication Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insomnia Medication Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Insomnia Medication Market Segments
Table 2. Ranking of Global Top Insomnia Medication Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insomnia Medication Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Nonbenzodiazepine Receptor Agonists
Table 5. Major Manufacturers of Benzodiazepine Receptor Agonists
Table 6. Major Manufacturers of The Selective Melatonin Receptor Agonist Ramelteon
Table 7. Major Manufacturers of Sedating Antidepressants
Table 8. Global Insomnia Medication Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Insomnia Medication Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Insomnia Medication Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Insomnia Medication Sales Market Share by Regions (2015-2020)
Table 12. Global Insomnia Medication Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Insomnia Medication Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Insomnia Medication Sales Share by Manufacturers (2015-2020)
Table 15. Global Insomnia Medication Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Insomnia Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Medication as of 2019)
Table 17. Insomnia Medication Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Insomnia Medication Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Insomnia Medication Price (2015-2020) (USD/Pcs)
Table 20. Insomnia Medication Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Insomnia Medication Product Type
Table 22. Date of International Manufacturers Enter into Insomnia Medication Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Insomnia Medication Sales by Type (2015-2020) (K Pcs)
Table 25. Global Insomnia Medication Sales Share by Type (2015-2020)
Table 26. Global Insomnia Medication Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Insomnia Medication Revenue Share by Type (2015-2020)
Table 28. Insomnia Medication Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Insomnia Medication Sales by Application (2015-2020) (K Pcs)
Table 30. Global Insomnia Medication Sales Share by Application (2015-2020)
Table 31. North America Insomnia Medication Sales by Country (2015-2020) (K Pcs)
Table 32. North America Insomnia Medication Sales Market Share by Country (2015-2020)
Table 33. North America Insomnia Medication Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Insomnia Medication Revenue Market Share by Country (2015-2020)
Table 35. North America Insomnia Medication Sales by Type (2015-2020) (K Pcs)
Table 36. North America Insomnia Medication Sales Market Share by Type (2015-2020)
Table 37. North America Insomnia Medication Sales by Application (2015-2020) (K Pcs)
Table 38. North America Insomnia Medication Sales Market Share by Application (2015-2020)
Table 39. Europe Insomnia Medication Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Insomnia Medication Sales Market Share by Country (2015-2020)
Table 41. Europe Insomnia Medication Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Insomnia Medication Revenue Market Share by Country (2015-2020)
Table 43. Europe Insomnia Medication Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Insomnia Medication Sales Market Share by Type (2015-2020)
Table 45. Europe Insomnia Medication Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Insomnia Medication Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Insomnia Medication Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Insomnia Medication Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Insomnia Medication Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Insomnia Medication Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Insomnia Medication Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Insomnia Medication Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Insomnia Medication Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Insomnia Medication Sales Market Share by Application (2015-2020)
Table 55. Latin America Insomnia Medication Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Insomnia Medication Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Insomnia Medication Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Insomnia Medication Revenue Market Share by Country (2015-2020)
Table 59. Latin America Insomnia Medication Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Insomnia Medication Sales Market Share by Type (2015-2020)
Table 61. Latin America Insomnia Medication Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Insomnia Medication Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Insomnia Medication Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Insomnia Medication Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Insomnia Medication Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Insomnia Medication Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Insomnia Medication Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Insomnia Medication Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Insomnia Medication Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Insomnia Medication Sales Market Share by Application (2015-2020)
Table 71. Eisai Corporation Information
Table 72. Eisai Description and Major Businesses
Table 73. Eisai Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Eisai Product
Table 75. Eisai Recent Development
Table 76. Merck Corporation Information
Table 77. Merck Description and Major Businesses
Table 78. Merck Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Merck Product
Table 80. Merck Recent Development
Table 81. Pfizer Corporation Information
Table 82. Pfizer Description and Major Businesses
Table 83. Pfizer Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Pfizer Product
Table 85. Pfizer Recent Development
Table 86. Sanofi Corporation Information
Table 87. Sanofi Description and Major Businesses
Table 88. Sanofi Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Sanofi Product
Table 90. Sanofi Recent Development
Table 91. Takeda Corporation Information
Table 92. Takeda Description and Major Businesses
Table 93. Takeda Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Takeda Product
Table 95. Takeda Recent Development
Table 96. Vanda Pharmaceuticals Corporation Information
Table 97. Vanda Pharmaceuticals Description and Major Businesses
Table 98. Vanda Pharmaceuticals Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Vanda Pharmaceuticals Product
Table 100. Vanda Pharmaceuticals Recent Development
Table 101. Astellas Corporation Information
Table 102. Astellas Description and Major Businesses
Table 103. Astellas Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Astellas Product
Table 105. Astellas Recent Development
Table 106. Dainippon Sumitomo Corporation Information
Table 107. Dainippon Sumitomo Description and Major Businesses
Table 108. Dainippon Sumitomo Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Dainippon Sumitomo Product
Table 110. Dainippon Sumitomo Recent Development
Table 111. ECR Pharmaceuticals (Valeant) Corporation Information
Table 112. ECR Pharmaceuticals (Valeant) Description and Major Businesses
Table 113. ECR Pharmaceuticals (Valeant) Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. ECR Pharmaceuticals (Valeant) Product
Table 115. ECR Pharmaceuticals (Valeant) Recent Development
Table 116. Flynn Pharma Corporation Information
Table 117. Flynn Pharma Description and Major Businesses
Table 118. Flynn Pharma Insomnia Medication Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Flynn Pharma Product
Table 120. Flynn Pharma Recent Development
Table 121. Johnson & Johnson Corporation Information
Table 122. Johnson & Johnson Description and Major Businesses
Table 123. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Johnson & Johnson Product
Table 125. Johnson & Johnson Recent Development
Table 126. Meda Corporation Information
Table 127. Meda Description and Major Businesses
Table 128. Meda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 129. Meda Product
Table 130. Meda Recent Development
Table 131. Somnus Therapeutics Corporation Information
Table 132. Somnus Therapeutics Description and Major Businesses
Table 133. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 134. Somnus Therapeutics Product
Table 135. Somnus Therapeutics Recent Development
Table 136. Purdue Pharma Corporation Information
Table 137. Purdue Pharma Description and Major Businesses
Table 138. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 139. Purdue Pharma Product
Table 140. Purdue Pharma Recent Development
Table 141. Neurim Corporation Information
Table 142. Neurim Description and Major Businesses
Table 143. Neurim Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 144. Neurim Product
Table 145. Neurim Recent Development
Table 146. Minerva Neurosciences Corporation Information
Table 147. Minerva Neurosciences Description and Major Businesses
Table 148. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 149. Minerva Neurosciences Product
Table 150. Minerva Neurosciences Recent Development
Table 151. Pernix Therapeutics Corporation Information
Table 152. Pernix Therapeutics Description and Major Businesses
Table 153. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 154. Pernix Therapeutics Product
Table 155. Pernix Therapeutics Recent Development
Table 156. SkyePharma Corporation Information
Table 157. SkyePharma Description and Major Businesses
Table 158. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 159. SkyePharma Product
Table 160. SkyePharma Recent Development
Table 161. Paratek Pharmaceuticals Corporation Information
Table 162. Paratek Pharmaceuticals Description and Major Businesses
Table 163. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 164. Paratek Pharmaceuticals Product
Table 165. Paratek Pharmaceuticals Recent Development
Table 166. Global Insomnia Medication Sales Forecast by Regions (2021-2026) (K Pcs)
Table 167. Global Insomnia Medication Sales Market Share Forecast by Regions (2021-2026)
Table 168. Global Insomnia Medication Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 169. Global Insomnia Medication Revenue Market Share Forecast by Regions (2021-2026)
Table 170. North America: Insomnia Medication Sales Forecast by Country (2021-2026) (K Pcs)
Table 171. North America: Insomnia Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Europe: Insomnia Medication Sales Forecast by Country (2021-2026) (K Pcs)
Table 173. Europe: Insomnia Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Asia Pacific: Insomnia Medication Sales Forecast by Region (2021-2026) (K Pcs)
Table 175. Asia Pacific: Insomnia Medication Revenue Forecast by Region (2021-2026) (US$ Million)
Table 176. Latin America: Insomnia Medication Sales Forecast by Country (2021-2026) (K Pcs)
Table 177. Latin America: Insomnia Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 178. Middle East and Africa: Insomnia Medication Sales Forecast by Country (2021-2026) (K Pcs)
Table 179. Middle East and Africa: Insomnia Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 180. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 181. Key Challenges
Table 182. Market Risks
Table 183. Main Points Interviewed from Key Insomnia Medication Players
Table 184. Insomnia Medication Customers List
Table 185. Insomnia Medication Distributors List
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Insomnia Medication Product Picture
Figure 2. Global Insomnia Medication Sales Market Share by Type in 2020 & 2026
Figure 3. Nonbenzodiazepine Receptor Agonists Product Picture
Figure 4. Benzodiazepine Receptor Agonists Product Picture
Figure 5. The Selective Melatonin Receptor Agonist Ramelteon Product Picture
Figure 6. Sedating Antidepressants Product Picture
Figure 7. Global Insomnia Medication Sales Market Share by Application in 2020 & 2026
Figure 8. Adults
Figure 9. Kids
Figure 10. Insomnia Medication Report Years Considered
Figure 11. Global Insomnia Medication Market Size 2015-2026 (US$ Million)
Figure 12. Global Insomnia Medication Sales 2015-2026 (K Pcs)
Figure 13. Global Insomnia Medication Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Insomnia Medication Sales Market Share by Region (2015-2020)
Figure 15. Global Insomnia Medication Sales Market Share by Region in 2019
Figure 16. Global Insomnia Medication Revenue Market Share by Region (2015-2020)
Figure 17. Global Insomnia Medication Revenue Market Share by Region in 2019
Figure 18. Global Insomnia Medication Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Insomnia Medication Revenue in 2019
Figure 20. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Insomnia Medication Sales Market Share by Type (2015-2020)
Figure 22. Global Insomnia Medication Sales Market Share by Type in 2019
Figure 23. Global Insomnia Medication Revenue Market Share by Type (2015-2020)
Figure 24. Global Insomnia Medication Revenue Market Share by Type in 2019
Figure 25. Global Insomnia Medication Market Share by Price Range (2015-2020)
Figure 26. Global Insomnia Medication Sales Market Share by Application (2015-2020)
Figure 27. Global Insomnia Medication Sales Market Share by Application in 2019
Figure 28. Global Insomnia Medication Revenue Market Share by Application (2015-2020)
Figure 29. Global Insomnia Medication Revenue Market Share by Application in 2019
Figure 30. North America Insomnia Medication Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Insomnia Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Insomnia Medication Sales Market Share by Country in 2019
Figure 33. North America Insomnia Medication Revenue Market Share by Country in 2019
Figure 34. U.S. Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Insomnia Medication Market Share by Type in 2019
Figure 39. North America Insomnia Medication Market Share by Application in 2019
Figure 40. Europe Insomnia Medication Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Insomnia Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Insomnia Medication Sales Market Share by Country in 2019
Figure 43. Europe Insomnia Medication Revenue Market Share by Country in 2019
Figure 44. Germany Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Insomnia Medication Market Share by Type in 2019
Figure 55. Europe Insomnia Medication Market Share by Application in 2019
Figure 56. Asia Pacific Insomnia Medication Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Insomnia Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Insomnia Medication Sales Market Share by Region in 2019
Figure 59. Asia Pacific Insomnia Medication Revenue Market Share by Region in 2019
Figure 60. China Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Insomnia Medication Market Share by Type in 2019
Figure 83. Asia Pacific Insomnia Medication Market Share by Application in 2019
Figure 84. Latin America Insomnia Medication Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Insomnia Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Insomnia Medication Sales Market Share by Country in 2019
Figure 87. Latin America Insomnia Medication Revenue Market Share by Country in 2019
Figure 88. Mexico Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Insomnia Medication Market Share by Type in 2019
Figure 95. Latin America Insomnia Medication Market Share by Application in 2019
Figure 96. Middle East and Africa Insomnia Medication Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Insomnia Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Insomnia Medication Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Insomnia Medication Revenue Market Share by Country in 2019
Figure 100. Turkey Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Insomnia Medication Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Insomnia Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Insomnia Medication Market Share by Type in 2019
Figure 107. Middle East and Africa Insomnia Medication Market Share by Application in 2019
Figure 108. North America Insomnia Medication Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Insomnia Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Insomnia Medication Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Insomnia Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Insomnia Medication Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Insomnia Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Insomnia Medication Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Insomnia Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Insomnia Medication Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Insomnia Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
不眠症の世界市場（～2026年） Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood. Sleep hygiene and lifestyle changes are typically the …- 薬物療法管理の世界市場（～2026年） Medication therapy management, generally called medicine use review in the United kingdom, is a service provided typically by pharmacists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. This includes providing educ…
- 自己管理薬の世界市場（～2026年） Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient. By distribution channel, the hospital pharmacies segment is expected to repr…
- 抗マラリア薬の世界市場（～2026年） Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. viva…
- ペット用医薬品の世界市場（～2026年） Market Analysis and Insights: Global Pet Medication Market The global Pet Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pet Medication Scope and Market Size Pet Medication market is segmented by Type, and …